Skip to main content
. 2022 Jun 14;33(8):836–844. doi: 10.1016/j.annonc.2022.04.071

Figure 3.

Figure 3

(A) Bar plot representing the number of newly enrolled patients to oncological clinical trials at the institution-wide level at DFCI and MSSM, across the different time periods (3-month intervals). (B) Racial distribution of newly enrolled patients to oncological clinical trials in the institution-wide cohort at DFCI during the studied time periods. (C) Age distribution among newly enrolled patients at DFCI (institution-wide level) during the different time periods, with pairwise comparisons (using Mann–Whitney U test). Only selected pairwise comparisons are shown in the figure, though all pairwise comparisons had P > 0.05.

DFCI, Dana-Farber Cancer Institute; MSSM, Mount Sinai School of Medicine.